Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel in Children and Adolescents

DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, presented a poster recently at SLEEP 2021, the …

Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel in Children and Adolescents Read More